Status | Study |
Completed |
Study Name: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Condition: Hyperparathyroidism, Secondary Date: 2013-02-07 Interventions: Drug: Etelcalcetide Administer |
Completed |
Study Name: Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Condition: Hyperparathyroidism, Secondary Date: 2013-02-05 Interventions: Drug: Etelcalcetide Administered by bolus injection into the venous line of the dialysis circuit at the |
Completed |
Study Name: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis Condition: Hyperparathyroidism, Secondary Date: 2013-02-05 Interventions: Drug: Etelcalcetide Administer |
Completed |
Study Name: A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism Condition: Secondary Hyperparathyroidism Date: 2012-07-25 Interventions: Drug: DP001 DP001 softgel capsules; 55 ng to 550 ng per dose, administered 3 times weekly for 4 weeks |
Terminated |
Study Name: Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism Condition: Secondary Hyperparathyroidism Date: 2012-04-05 Interventions: Drug: Etelcalcetide Administered as an intravenous bolus three times a week at the end of each hemodialy |
Terminated |
Study Name: Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism Condition: Chronic Kidney Disease Hyperparathyroidism, Secondary Date: 2011-09-22 Interventions: Drug: Cinacalcet hydrochloride |
Completed |
Study Name: Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism Condition: Secondary Hyperparathyroidism Date: 2010-12-03 Interventions: Drug: Etelcalcetide Administer |
Completed |
Study Name: Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis Condition: Hyperparathyroidism, Secondary Date: 2010-08-12 Interventions: Drug: Traditional Vitamin D Therapy |
Completed |
Study Name: LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients Condition: Secondary Hyperparathyroidism Date: 2010-07-02 Interventions: Drug: LEO 27847 First in patient |
Completed |
Study Name: Safety, Tolerability and Pharmacokinetics of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism Condition: Hyperparathyroidism, Secondary Date: 2010-05-28 Interventions: Drug: Saline Single IV injecti |